Delivery Order SPE2DE24DA017-SPE2D625F1GBU
- Not listed
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $7,063.32 for a Locking Distal Fibula Plate (titanium, left, 6-hole configuration) by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 20, 2025, and will be performed at Arthrex's Naples, Florida facility. The award utilizes no set-aside...
- Arthrex Inc., a leading global developer and manufacturer of minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $2,626.80 by the Defense Logistics Agency's Medical Supply Chain for posterior anatomical distal fibula plate with titanium and locking technology. The contract, awarded on July 28, 2025, with a completion date of July 31, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $2,791.26 for a Locking Distal Fibula Plate (titanium, left, 5-hole configuration) under the Defense Logistics Agency's Medical Supply Chain contract. The award, issued on August 7, 2025, with an ultimate completion date of August 18, 2025, represents a fixed-price delivery order with economic price adjustment provisions. This delivery order is issued...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a delivery order from the Defense Logistics Agency's Medical Supply Chain for a locking distal fibula plate (titanium, left, 5-hole configuration) valued at $5,786.58. This fixed-price contract with economic price adjustment was awarded on August 7, 2025, with an ultimate completion date of August 12, 2025. The order will be fulfilled at Arthrex's facility in Naples, Florida, and...
- Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $3,791.55 on August 4, 2025, for a Locking Distal Fibula Plate in titanium (right-sided, 6-hole configuration). The contract is fixed-price with economic price adjustment and carries an ultimate completion date of August 7, 2025. This delivery order falls under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- On August 8, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,328.58 to Arthrex Inc. for a locking distal fibula plate manufactured in titanium for right-sided applications. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by August 13, 2025, and will be performed in Naples, Florida. The award represents a task order executed under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with...
- This is a delivery order award by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in orthopedic medical technologies based in Naples, Florida. The contract is for the supply of a locking distal fibula plate, titanium, left, size 5H, with a ceiling value of $4,242.75. The award has an ultimate completion date of January 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Arthrex and the Defense Logistics Agency,...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $2,924.08 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The delivery order, which calls for a titanium locking plate (part number 4569130255), carries an ultimate completion date of August 21, 2025, and includes economic price adjustment provisions. This award represents an open competition with no set-aside...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $7,440.74 for a Locking Third Tubular Plate made of titanium (8H specification). The contract, issued by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, utilizes a fixed price with economic price adjustment pricing model and is scheduled for completion by July 23, 2025. This delivery order is not set aside for any specific...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order for a wide T-plate (2.4mm, 6-hole) component valued at $3,481.38. This fixed-price delivery order with economic price adjustment adjustment was issued on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of August 14, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F1GBUDelivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $6,561.10 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, for a locking distal fibula plate in titanium (right side, 5-hole configuration). This fixed-price delivery order with economic price adjustment represents completion by August 21, 2025, and carries no set-aside designation, reflecting Arthrex's strong competitive standing in federal healthcare procurement. The award was issued under Arthrex's substantial single-award Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million through September 2029, which enables Department of Veterans Affairs medical centers nationwide to procure the company's comprehensive orthopedic product portfolio. This delivery order for specialized foot and ankle surgical implant technology aligns with Arthrex's core competency in minimally invasive orthopedic solutions and its established role as a primary supplier of surgical instruments, implants, and biologics to the federal healthcare system. The company's ability to fulfill this requirement through the existing indefinite delivery vehicle demonstrates its capacity to support government healthcare systems, including the VA and Department of Defense, with advanced orthopedic technologies tailored to meet the medical needs of veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 8/18/25 |